These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2072930)

  • 21. A truncated human insulin receptor missing the COOH-terminal 365 amino acid residues does not undergo insulin-mediated receptor migration or aggregation.
    Smith RM; Sasaoka T; Shah N; Takata Y; Kusari J; Olefsky JM; Jarett L
    Endocrinology; 1993 Apr; 132(4):1453-62. PubMed ID: 8462446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics.
    Vogt B; Carrascosa JM; Ermel B; Ullrich A; Häring HU
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1013-8. PubMed ID: 1647764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.
    Maegawa H; McClain DA; Freidenberg G; Olefsky JM; Napier M; Lipari T; Dull TJ; Lee J; Ullrich A
    J Biol Chem; 1988 Jun; 263(18):8912-7. PubMed ID: 2837468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin.
    Berti L; Kellerer M; Bossenmaier B; Seffer E; Seipke G; Häring HU
    Horm Metab Res; 1998 Mar; 30(3):123-9. PubMed ID: 9566852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling.
    Fiory F; Alberobello AT; Miele C; Oriente F; Esposito I; Corbo V; Ruvo M; Tizzano B; Rasmussen TE; Gammeltoft S; Formisano P; Beguinot F
    Mol Cell Biol; 2005 Dec; 25(24):10803-14. PubMed ID: 16314505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of phosphatidylinositol-3-kinase by insulin is mediated by both A and B human insulin receptor types.
    Carrascosa JM; Vogt B; Ullrich A; Häring HU
    Biochem Biophys Res Commun; 1991 Jan; 174(1):123-7. PubMed ID: 1846534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose and insulin regulate insulin sensitivity in primary cultured adipocytes without affecting insulin receptor kinase activity.
    Lima FB; Thies RS; Garvey WT
    Endocrinology; 1991 May; 128(5):2415-26. PubMed ID: 2019259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors.
    Grako KA; Olefsky JM; McClain DA
    Endocrinology; 1992 Jun; 130(6):3441-52. PubMed ID: 1317784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NPEY sequence is not necessary for endocytosis and processing of insulin-receptor complexes.
    Berhanu P; Ibrahim-Schneck RH; Anderson C; Wood WM
    Mol Endocrinol; 1991 Dec; 5(12):1827-35. PubMed ID: 1791832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of Asn281 in the alpha-subunit of the human insulin receptor causes constitutive activation of the receptor and insulin desensitization.
    Desbois-Mouthon C; Sert-Langeron C; Magre J; Oreal E; Blivet MJ; Flori E; Besmond C; Capeau J; Caron M
    J Clin Endocrinol Metab; 1996 Feb; 81(2):719-27. PubMed ID: 8636294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies.
    Huang Z; Bodkin NL; Ortmeyer HK; Zenilman ME; Webster NJ; Hansen BC; Shuldiner AR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1552-6. PubMed ID: 8636366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin receptor transmembrane signaling: evidence for an intermolecular oligomerization mechanism of activation.
    Mynarcik DC; Whittaker J
    J Recept Signal Transduct Res; 1995; 15(7-8):887-904. PubMed ID: 8673722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (non-insulin-dependent) diabetic subjects.
    Kellerer M; Sesti G; Seffer E; Obermaier-Kusser B; Pongratz DE; Mosthaf L; Häring HU
    Diabetologia; 1993 Jul; 36(7):628-32. PubMed ID: 8359580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of receptor-mediated transmembrane communication.
    Ellis L; Morgan DO; Clauser E; Edery M; Jong SM; Wang LH; Roth RA; Rutter WJ
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():773-84. PubMed ID: 3472760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B.
    Giudice J; Leskow FC; Arndt-Jovin DJ; Jovin TM; Jares-Erijman EA
    J Cell Sci; 2011 Mar; 124(Pt 5):801-11. PubMed ID: 21303927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes.
    Nevado C; Valverde AM; Benito M
    Endocrinology; 2006 Aug; 147(8):3709-18. PubMed ID: 16644916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence supporting a two-receptor model for insulin binding by cultured embryonic heart cells.
    Wheeler FB; Santora AC; Elsas LJ
    Endocrinology; 1980 Jul; 107(1):195-207. PubMed ID: 6991248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I; Foti M; Emkey R; Cordier-Bussat M; Philippe J; De Meyts P; Maeder C; Kahn CR; Carpentier JL
    Diabetologia; 2002 May; 45(5):657-67. PubMed ID: 12107746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of insulin receptors in rat tissues as detected with the partial agonist B29,B29'-suberoyl-insulin.
    Breiner M; Weiland M; Becker W; Müller-Wieland D; Streicher R; Fabry M; Joost HG
    Mol Pharmacol; 1993 Aug; 44(2):271-6. PubMed ID: 8355664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmembrane domain interactions are necessary for negative cooperativity of the insulin receptor.
    Whittaker J; Garcia P; Yu GQ; Mynarcik DC
    Mol Endocrinol; 1994 Nov; 8(11):1521-7. PubMed ID: 7877620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.